Merck

howdy everyone, certainly never expected this news, James was right, we got something from left field

just got the countries wrong....you'll need to pick your act up there mate, haha....

back to the serious stuff though....I have little doubt Merck have have seen something in "Efti" that has

given them cause for a serious look into combo trials with Immutep.....The fact they have convinced

Pfizer to engage in a shared  product combo with a little Aussie biotech should not be dismissed lightly.....

The announcement re trial initiation per se was not outstanding (ph1) but the participants are, One senses

Immutep are on the cusp here.......We have to remember Novartis and GSK were inherited partnerships

from the Immutep SA days along with Eddingpharm, New partners Merck and Pfizer whilst obviously being

new are taking on a product with 8 years additional development than the GSK,etc deals and engaging in

a far more bouyant space with the rapidly increasing I/O/therapy landscape......Courtesy of the Aust Govt.

and it's generous PBS scheme someone in Immutep had the "brainwave" to commence a combo with

keytruda.....That decision could well be a company changer.....